{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
NCT04435691: Phase 1/Phase 2 Interventional Active, not recruiting Acute Myeloid Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02350673: Phase 1 Interventional Completed Solid Tumors
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01760005: Phase 2/Phase 3 Interventional Recruiting Alzheimers Disease
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02657915: Phase 2 Interventional Completed Acute Optic Neuritis
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03290781: Phase 3 Interventional Completed Ulcerative Colitis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lutetium (¹⁷⁷Lu) lilotomab satetraxetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02657447: Phase 1 Interventional Withdrawn Non-Hodgkin Lymphoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03539536: Phase 2 Interventional Active, not recruiting Non-small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03013998: Phase 1/Phase 2 Interventional Recruiting Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03856047: Phase 2 Interventional Completed Overweight
(2019)
Source URL:
Class:
PROTEIN
